Blog

Attention deficit hyperactivity disorder (ADHD) is often considered a childhood disorder that diminishes in adulthood. But it can also be diagnosed in adults.

In the United States, 15.5 million adults have been diagnosed with ADHD or attention deficit/hyperactivity disorder. More than half who received their diagnosis in adulthood experience symptoms that include trouble paying close attention to details, sustaining attention, following instructions, forgetfulness, talking excessively and/or interrupting.

“There used to be an old saying that people who had ADHD would grow out of it,” explains clinical psychologist Patrick Moran, Director of Sales, Government and Public Safety at Pearson Clinical Assessment. “I think what really happened is that they would learn compensatory coping skills so that they could do some of the downregulation with their emotions and behaviors. In essence, they just got better at managing it, so it was less obvious to the external observer.”

In simple terms, the WAIS®-5 is the best test we've ever produced in the cognitive line in so many ways. There are many updates test users are going to be excited about.

Hello everyone! I am Kristen Getz, the Product Owner (PO) of Q-interactive®. As the PO, my main role is to champion the customer’s needs throughout the product development journey. Before joining Pearson, I spent 14 years in clinical practice. At Pearson I have been focused on developing tests and improving our platforms for clinicians. My passion for assessments comes from my experience working with children and adults, aiming to create products that are psychometrically sound and user-friendly while saving valuable time.

The Q-interactive platform embodies everything I believe in and strive for: precision, intuitiveness, and innovation. Q-interactive is revolutionizing the field of psychological assessment, offering more accurate and creative ways to measure constructs. The new app's underlying technology has unlocked a plethora of new features that we will be gradually releasing, all based on feedback from you, our valued customers. Stay tuned because we know you will be excited about what is coming next!

We are proud to announce the new Call for Research published by Pearson Clinical Assessment. Our goal is to ensure that Pearson assessments comply with the highest standards of quality and support research that investigates the validity or efficacy of our products. We are inviting United States-based faculty members, graduate students, and qualified researchers to submit their proposals no later than August 16, 2024.

It's early morning, the sun is barely rising, and your only desire is a cup of coffee to kickstart your day. As you head toward the kitchen, a fresh plan brewing in your mind, your phone buzzes and it’s an email from work! Could it be important? You decide to check. Turns out, it's only spam, so you quickly delete it and continue to the kitchen. But then you pause, your mind suddenly drawing a blank.

There’s a lot happening over here as we develop the new WAIS-5. We wanted to share our latest updates as we get closer to releasing this new assessment. The Wechsler Adult Intelligence Scale®, Fifth Edition (WAIS®-5) is the most advanced psychometric measure of cognitive abilities and now it can be administered in less time. And that is not all! WAIS-5 also features updated norms, expanded clinical utility, and improved user experience.

Check out the latest details on these enhancements, plus learn about five of the new subtests.

As with anything else, there is a “recipe for success” for using Cogmed working memory training, and following it closely almost always leads to the best outcome. I'm Kyra Minichan, Pearson Healthcare Assessment Consultant and SLP for 30 years and I wanted to share with you MY recipe for success in using Cogmed in my practice.

We are proud to announce the new Call for Research published by Pearson Clinical Assessment. Our goal is to ensure that Pearson assessments comply with the highest standards of quality and support research that investigates the validity or efficacy of our products. We are inviting United States-based faculty members, graduate students, and qualified researchers to submit their proposals no later than August 11, 2023.

Here’s what you need to know...